Daily notes / October 19, 2026
Daniel Dines reported a 1,250,000-share UiPath sale on Form 4
Written by a model from the facts OQRO holds and checked against them, sentence by sentence of . Published . 3 min read.

The short answer
Daniel Dines, CEO and Chairman at UiPath, reported an open-market sale of 1,250,000 shares at $13.44 each, about $16.8M in total. The transaction date was Oct 15, 2026, and the Form 4 was filed on Oct 19, 2026. The filing also mentions a planned or automatic transaction, but does not say why the sale was made.
What did Daniel Dines report?
The SEC Form 4 reports an open-market sale by Daniel Dines, CEO and Chairman at UiPath (PATH). The reported transaction was 1,250,000 shares at $13.44 each, about $16.8M.
The transaction date was Oct 15, 2026. The Form 4 was filed on Oct 19, 2026, 4 days later.
How does the sale fit the timing of company results?
The trade was made 42 days after UiPath's results announcement of Sep 3, 2026, reported under 8-K Item 2.02. In the 455 days to Oct 19, 2026, OQRO holds 88 open-market sales by UiPath insiders, counted once per person and day. Of those, 35 were made within 30 days after a results announcement.
As general background, many companies let insiders trade only in a window that opens after results. A sale can also follow an option exercise, a tax bill or a pre-arranged plan. The Form 4 does not say which of these applies here.
How does this compare with other UiPath sales?
In the 365 days to Oct 19, 2026, OQRO holds 47 other open-market sales by Daniel Dines, about $71.5M in total. All 47 were at UiPath.
In the 90 days to Oct 19, 2026, OQRO holds 11 other open-market sales at UiPath, about $44.8M, by 5 insiders. In the 365 days before that, 91 were filed, about $80.3M, an average of 22.4 per 90 days. These comparisons use only the filings OQRO holds.
What other filings and records are on record?
The largest other filings of the same kind in the period were by Ashim Gupta, COO, about $1.63M on Sep 15, 2026 and Raghavendra Malpani, CPO & CTO, about $1.36M on Sep 18, 2026. Fund 13F filings recorded in the 90 days to Oct 19, 2026 show 1 new or larger position and 3 smaller or closed positions in UiPath.
For the quarter ended Jun 30, 2026, the largest positions that grew were Jupiter Asset Management Ltd, increased by 5,251,946 shares, and Hillsdale Investment Management Inc., increased by 81,470 shares. The largest that shrank were Eventide Asset Management, LLC and Caisse de depot et placement du Quebec, both sold out. A 13F is a quarter-end snapshot with no trade date.
FINRA short interest for PATH on the settlement date of Sep 30, 2026 was 108,422,862 shares, +4.05% on the previous report, or about 2.31 days of average volume. OQRO’s UiPath page provides the company filing context.
What was reported around the transaction date?
PATH closed at $13.71 on Oct 15, 2026, the last session on or before the trade date. From Sep 15, 2026 to Oct 15, 2026, the close moved from $14.23 to $13.71, a change of −3.7%. From Oct 15, 2026 to Oct 19, 2026, the close moved from $13.71 to $13.12, a change of −4.3%. These price moves are context only; the filing does not explain them, and other news can move a price.
Finnhub listed the Yahoo headline “Wix, UiPath, SentinelOne, Amplitude, and Commvault Stocks Trade Down, What You Need To Know” on Oct 16, 2026, and “Figma vs. UiPath: What Revenue Growth Trends Tell Investors About These Tech Companies” on Oct 14, 2026. These are headlines listed as published by the outlets; OQRO has not checked them and does not summarize the articles.
What this does not tell you?
A Form 4 reports a transaction; it does not say why it was made. Some purchases and sales follow trading windows or pre-arranged plans, and OQRO notes a plan only when a filing footnote says so. A footnote of this filing mentions a planned or automatic transaction, but the filing does not establish why the sale occurred.
The filing does not explain the share-price moves, and other news can move a price. The comparisons in this article use only the filings OQRO holds. This describes public filings and is not investment advice.
Sources
A model wrote this page from the facts OQRO holds; every number, date, name and link in it was checked against those facts before publication, and a text that failed the check was not published. It describes what was filed, not why, and it is not investment advice. How OQRO treats data
Explore the data
More daily notes
- Chernett Jorey reported an Exagen share purchase on Form 4
- Robert Nelsen reported a City Therapeutics open-market purchase
- Control Empresarial reported a Talos Energy share sale on Form 4
- Harel filed a Schedule 13G reporting a 5.2% stake in Elbit Systems
- JP Sailing Capital filed a Schedule 13G on Nextcure
- Norbel Investments filed a Schedule 13G on Papa John's Pizza